Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anthracycline cardiomyopathy monitored by morphologic changes.

M E Billingham, J W Mason, M R Bristow

    Cancer Treatment Reports
    |June 1, 1978
    PubMed
    Summary

    Adriamycin (ADM) and similar chemotherapy drugs can cause heart damage. Previous radiation therapy significantly worsens this cardiotoxicity, highlighting the need for careful monitoring during cancer treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Comparison of PR, QRS, and QT interval measurements by seven ECG interpretation programs.

    Journal of electrocardiology·2020
    Same author

    Tobacco.

    The American journal of dental science·2019
    Same author

    Late sodium current block for drug-induced long QT syndrome: Results from a prospective clinical trial.

    Clinical pharmacology and therapeutics·2015
    Same author

    Lacosamide cardiac safety: clinical trials in patients with partial-onset seizures.

    Acta neurologica Scandinavica·2015
    Same author

    Differentiating drug-induced multichannel block on the electrocardiogram: randomized study of dofetilide, quinidine, ranolazine, and verapamil.

    Clinical pharmacology and therapeutics·2014
    Same author

    Collagenolytic activity of synovium in rheumatoid arthritis.

    The New England journal of medicine·2010

    Area of Science:

    • Cardiology
    • Oncology
    • Pathology

    Background:

    • Anthracyclines, such as Adriamycin (ADM), are widely used chemotherapy agents.
    • Anthracycline therapy is associated with potential cardiotoxicity, affecting cardiac myocytes.
    • Previous mediastinal irradiation may influence the heart's susceptibility to subsequent therapies.

    Purpose of the Study:

    • To investigate the cardiotoxic effects of Adriamycin (ADM) and related anthracycline analogs.
    • To evaluate the impact of prior mediastinal irradiation on ADM-induced cardiac pathology.
    • To assess the utility of endomyocardial biopsy in monitoring anthracycline cardiotoxicity.

    Main Methods:

    • Analysis of 76 endomyocardial biopsies from 60 patients treated with ADM or analogs.
    • Histopathological examination using light and electron microscopy.
    • Grading of myocyte degeneration severity (0-3 scale) and comparison between irradiated and non-irradiated groups.

    Main Results:

    • Two consistent types of focal myocyte degeneration were observed, without inflammatory infiltrate.
    • Patients with prior mediastinal irradiation showed significantly higher ADM-induced cardiotoxicity (mean grade 2.0) compared to non-irradiated patients (mean grade 1.18).
    • Similar cellular lesions were noted in animal models and with other anthracycline analogs (adria-DNA, rubidazone).

    Conclusions:

    • Remote radiation exposure potentiates ADM-induced cardiotoxicity, potentially through a "recall" phenomenon.
    • Anthracycline therapy can induce progressive, subclinical cardiac injury undetectable by conventional tests.
    • Endomyocardial biopsy is a reliable method for monitoring anthracycline-induced cardiac damage in humans.

    Related Experiment Videos